Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

White Meets Blue - Enzymicals AG and the Institute of Marine Biotechnologye.V. start to cooperate

14.06.2011
The Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future.The two institutions both located in Greifswald, Germany, combine thereby their competencies in the commercialization of alternative expression systems and functional genome analysisfor the production of fine chemicals.

The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources,amongst others. “Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology”, says Prof. Dr. Thomas Schweder of the IMaB. ”Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.”

Thewhole value chain can be covered jointly by merchandising of new biocatalysts from aquatic systems and the application-oriented process development by Enzymicals AG.

The two institutionscomplement each other in their strategic alignment perfectly by the construction of expression systems and production strains for applications in fine chemistry.

“Thus, our customers will gain access to exquisite biocatalysts for applications in the chemical and pharmaceutical industry”, adds Dr. Ulf Menyes, CEO of Enzymicals AG, who foresees a strengthening of core competencies by the partnership.

Both new and existing customers will gain a long-term competitive advantage in tailored product and process development based on innovative biocatalysts from the cooperation of both institutions.

About Enzymicals AG:
The Enzymicals AG, Greifswald, was founded as a start-up company in August 2009, initialized by the workgroup of Prof. UweBornscheuer, Institute of Biochemistry at the University of Greifswald. The company specializes in enzymatic reactions for the production of fine and specialty chemicals and the manufacture and sale of biocatalysts.

The interdisciplinary team of biochemists, biologists, synthetic and process chemists is led by Dr. Ulf Menyes (chemist) as chief executive officer (CEO) and Dr. Rainer Wardenga (biologist) as head of research and production (CSO). The Enzymicals AG has establishedcollaborations with leading companies in the chemical industry and established the technical requirements for the production of enzymes and for the biotechnological synthesis of specialty and fine chemicals on kg-scalewithin a short period of time. Enzymicals is member of BioCon Valley MV e.V.

About the Institute of Marine Biotechnologye.V.:
The Institute of Marine Biotechnology e.V. (IMaB) was founded in 1996. The main concern of the institute is to promote and develop research in the field of marine biotechnology. This is done in close cooperation with the Ernst-Moritz-ArndtUniversity of Greifswald. Research interests of the IMaB include the functional genome and proteome analysis of marine microorganisms, the discovery, enrichment and characterization of bioactive compounds from marine organisms and the development of new bacterial expression systems.

A particular focus is on the field of functional genomics of marine microorganisms. The increasing number of sequenced genomes of marine bacteria and the extensive data on marine metagenomes allow a comprehensive insight into the previously unknown metabolic activities of marine organisms. The functional genome analysis is substantially supported by the analysis of the physiological proteome. One of the most modern and best equipped proteome centers in Germany was established at the University of Greifswald in recent years. These technologies are used by the IMaB to determine relevant, new gene functions and to make them accessible for biotechnological applications. The Institute is member of BioCon Valley MV e.V.

Contact:
Enzymicals AG
Dr. Ulf Menyes, CEO
Walther-Rathenau-Str. 49a
17489 Greifswald, Germany
Tel.: +49-3834-515 470
Fax.: +49-3834-515 473
E-Mail: ulf.menyes@enzymicals.com
Institutfür Marine Biotechnologiee.V.
Prof. Dr. Thomas Schweder
Walther-Rathenau-Str. 49A
D-17489 Greifswald
Tel.: +49(0)3834 864212
Fax +49(0)3834 864238
E-Mail: schweder@uni-greifswald.de

Dr. Heinrich Cuypers | idw
Further information:
http://www.enzymicals.com
http://www.marine-biotechnologie.de
http://www.bcv.org

More articles from Life Sciences:

nachricht Nesting aids make agricultural fields attractive for bees
20.07.2017 | Julius-Maximilians-Universität Würzburg

nachricht The Kitchen Sponge – Breeding Ground for Germs
20.07.2017 | Hochschule Furtwangen

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

Leipzig HTP-Forum discusses "hydrothermal processes" as a key technology for a biobased economy

12.07.2017 | Event News

 
Latest News

Researchers create new technique for manipulating polarization of terahertz radiation

20.07.2017 | Information Technology

High-tech sensing illuminates concrete stress testing

20.07.2017 | Materials Sciences

First direct observation and measurement of ultra-fast moving vortices in superconductors

20.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>